(Q35085078)

English

Comparison of outcomes of allogeneic transplantation for chronic myeloid leukemia with cyclophosphamide in combination with intravenous busulfan, oral busulfan, or total body irradiation

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

6 August 2017

Comparison of outcomes of allogeneic transplantation for chronic myeloid leukemia with cyclophosphamide in combination with intravenous busulfan, oral busulfan, or total body irradiation (English)

1 reference

Europe PubMed Central

6 August 2017

chronic myeloid leukemia

0 references

Robert Peter Gale

5

object named as

Robert Peter Gale

1 reference

Europe PubMed Central

6 August 2017

Jorge Eduardo Cortes

35

object named as

Jorge Cortes

1 reference

Europe PubMed Central

6 August 2017

20

object named as

Harry C Schouten

1 reference

Europe PubMed Central

6 August 2017

Alison Wakoff Loren

33

object named as

Alison W Loren

1 reference

Europe PubMed Central

6 August 2017

22

object named as

Mark R Litzow

1 reference

Europe PubMed Central

6 August 2017

Edmund K Waller

11

object named as

Edmund K Waller

1 reference

Europe PubMed Central

6 August 2017

author name string

Edward A Copelan

1

1 reference

Europe PubMed Central

6 August 2017

Belinda R Avalos

2

1 reference

Europe PubMed Central

6 August 2017

Kwang Woo Ahn

3

1 reference

Europe PubMed Central

6 August 2017

Xiaochun Zhu

4

1 reference

Europe PubMed Central

6 August 2017

Michael R Grunwald

6

1 reference

Europe PubMed Central

6 August 2017

Mehdi Hamadani

7

1 reference

Europe PubMed Central

6 August 2017

Betty K Hamilton

8

1 reference

Europe PubMed Central

6 August 2017

Gregory A Hale

9

1 reference

Europe PubMed Central

6 August 2017

David I Marks

10

1 reference

Europe PubMed Central

6 August 2017

Bipin N Savani

12

1 reference

Europe PubMed Central

6 August 2017

Luciano J Costa

13

1 reference

Europe PubMed Central

6 August 2017

Muthalagu Ramanathan

14

1 reference

Europe PubMed Central

6 August 2017

Jean-Yves Cahn

15

1 reference

Europe PubMed Central

6 August 2017

H Jean Khoury

16

1 reference

Europe PubMed Central

6 August 2017

Daniel J Weisdorf

17

1 reference

Europe PubMed Central

6 August 2017

Yoshihiro Inamoto

18

1 reference

Europe PubMed Central

6 August 2017

Rammurti T Kamble

19

1 reference

Europe PubMed Central

6 August 2017

Baldeep Wirk

21

1 reference

Europe PubMed Central

6 August 2017

Mahmoud D Aljurf

23

1 reference

Europe PubMed Central

6 August 2017

Koen W van Besien

24

1 reference

Europe PubMed Central

6 August 2017

Celalettin Ustun

25

1 reference

Europe PubMed Central

6 August 2017

Brian J Bolwell

26

1 reference

Europe PubMed Central

6 August 2017

Christopher N Bredeson

27

1 reference

Europe PubMed Central

6 August 2017

Omotayo Fasan

28

1 reference

Europe PubMed Central

6 August 2017

Nilanjan Ghosh

29

1 reference

Europe PubMed Central

6 August 2017

Mary M Horowitz

30

1 reference

Europe PubMed Central

6 August 2017

Mukta Arora

31

1 reference

Europe PubMed Central

6 August 2017

Jeffrey Szer

32

1 reference

Europe PubMed Central

6 August 2017

Edwin P Alyea

34

1 reference

Europe PubMed Central

6 August 2017

Richard T Maziarz

36

1 reference

Europe PubMed Central

6 August 2017

Matt E Kalaycio

37

1 reference

Europe PubMed Central

6 August 2017

Wael Saber

38

1 reference

Europe PubMed Central

6 August 2017

publication date

17 December 2014

1 reference

Europe PubMed Central

6 August 2017

Biology of Blood and Marrow Transplantation

1 reference

Europe PubMed Central

6 August 2017

21

1 reference

Europe PubMed Central

6 August 2017

3

1 reference

Europe PubMed Central

6 August 2017

552-558

1 reference

Europe PubMed Central

6 August 2017

Hematopoietic SCT in Europe: data and trends in 2012 with special consideration of pediatric transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4329042

8 July 2018

Prospective cohort study comparing intravenous busulfan to total body irradiation in hematopoietic cell transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4329042

8 July 2018

Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4329042

8 July 2018

European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4329042

8 July 2018

Quantitative and qualitative differences in use and trends of hematopoietic stem cell transplantation: a Global Observational Study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4329042

8 July 2018

Variation in prescribing patterns and therapeutic drug monitoring of intravenous busulfan in pediatric hematopoietic cell transplant recipients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4329042

8 July 2018

Pharmacokinetic targeting of intravenous busulfan reduces conditioning regimen related toxicity following allogeneic hematopoietic cell transplantation for acute myelogenous leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4329042

8 July 2018

Impact of prior imatinib mesylate on the outcome of hematopoietic cell transplantation for chronic myeloid leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4329042

8 July 2018

Classification of HLA-matching for retrospective analysis of unrelated donor transplantation: revised definitions to predict survival

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4329042

8 July 2018

Myeloablative conditioning regimens for AML allografts: 30 years later

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4329042

8 July 2018

Intravenous versus oral busulfan as part of a busulfan/cyclophosphamide preparative regimen for allogeneic hematopoietic stem cell transplantation: decreased incidence of hepatic venoocclusive disease (HVOD), HVOD-related mortality, and overall 100-

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4329042

8 July 2018

Plasma concentration monitoring of busulfan: does it improve clinical outcome?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4329042

8 July 2018

Marrow transplantation for chronic myeloid leukemia: a randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4329042

8 July 2018

1994 Consensus Conference on Acute GVHD Grading

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4329042

8 July 2018

Busulfan kinetics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4329042

8 July 2018

Treatment of chronic myeloid leukemia with allogeneic bone marrow transplantation after preparation with BuCy2

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4329042

8 July 2018

Busulfan or TBI: answer to an age-old question

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4329042

27 September 2018

Thirteen years' experience of pharmacokinetic monitoring and dosing of busulfan: can the strategy be improved?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4329042

27 September 2018

Allogeneic hematopoietic stem-cell transplantation for acute myeloid leukemia in remission: comparison of intravenous busulfan plus cyclophosphamide (Cy) versus total-body irradiation plus Cy as conditioning regimen--a report from the acute leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4329042

27 September 2018

A SAS macro for estimation of direct adjusted survival curves based on a stratified Cox regression model.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4329042

27 September 2018

HLA-matched related hematopoietic cell transplantation for chronic-phase CML using a targeted busulfan and cyclophosphamide preparative regimen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4329042

27 September 2018

Conditioning therapy with intravenous busulfan and cyclophosphamide (IV BuCy2) for hematologic malignancies prior to allogeneic stem cell transplantation: a phase II study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4329042

27 September 2018

Marrow transplantation for chronic myeloid leukemia: the influence of plasma busulfan levels on the outcome of transplantation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4329042

27 September 2018

Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4329042

27 September 2018

Bone Marrow Transplantation for Patients with Chronic Myeloid Leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4329042

16 November 2018

Treatment of chronic granulocytic leukaemia in chronic phase by allogeneic marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/25528388

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Marrow transplantation for patients in the chronic phase of chronic granulocytic leukaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/25528388

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Marrow transplantation for the treatment of chronic myelogenous leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/25528388

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of busulfan: correlation with veno-occlusive disease in patients undergoing bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/25528388

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allogeneic bone marrow transplantation for acute myeloid leukemia in first remission: a randomized trial of a busulfan-Cytoxan versus Cytoxan-total body irradiation as preparative regimen: a report from the Group d'Etudes de la Greffe de Moelle Osse

1 reference

https://pubmed.ncbi.nlm.nih.gov/25528388

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allogeneic bone marrow transplantation for chronic myeloid leukemia in first chronic phase: a randomized trial of busulfan-cytoxan versus cytoxan-total body irradiation as preparative regimen: a report from the French Society of Bone Marrow Graft (S

1 reference

https://pubmed.ncbi.nlm.nih.gov/25528388

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Graft-rejection and toxicity following bone marrow transplantation in relation to busulfan pharmacokinetics

1 reference

https://pubmed.ncbi.nlm.nih.gov/25528388

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relapse of chronic myeloid leukemia after allogeneic stem cell transplantation: outcome and prognostic factors. The Chronic Myeloid Leukemia Subcommittee of the GETH (Grupo Español de Trasplante Hemopoyético)

1 reference

https://pubmed.ncbi.nlm.nih.gov/25528388

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.BBMT.2014.12.010

1 reference

Europe PubMed Central

6 August 2017

1 reference

Europe PubMed Central

6 August 2017

1 reference

Europe PubMed Central

6 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35085078&oldid=2012180028"